title: [Non-antibiotic anti-infectious treatments in urology].
abstract: OBJECTIVE
  To define the terms of use of pesticides, antifungal, antiviral and antiseptic treatments in urology.
  
  
  METHODS
  A literature search was conducted on MEDLINE for all these treatments used in urology. The molecules were classified by family. Modes of action, indications in urology and adverse effects have been detailed. Authorisation files were consulted and then complemented by a literature analysis.
  
  
  RESULTS
  Although parasitic or viral diseases are uncommon in urology, their specific treatment deserves a thorough knowledge of pesticide and antiviral molecules. Antifungal treatments are regularly used in urology with special features to know to improve the efficacy/safety ratio. Antiseptics are used daily in urology and a better understanding of these molecules allows better use.
  
  
  CONCLUSIONS
  Beyond antibiotics, antiviral, antiparasitic and antifungal deserve a thorough knowledge. Antiseptic although used daily have features little known.
authors.affiliation: Service d'urologie, CHRU Bretonneau, 2, boulevard Tonnellé, 37044 Tours cedex, France; Université François-Rabelais de Tours, PRES Centre Val-de-Loire université, 37000 Tours, France. Electronic address: f.bruyere@chu-tours.fr.
authors.forename: F
authors.initials: F
authors.lastname: Bruyère
authors.forename: G
authors.initials: G
authors.lastname: Desoubeaux
authors.forename: S
authors.initials: S
authors.lastname: Malavaud
authors.forename: C
authors.initials: C
authors.lastname: Fourcade
authors.forename: J
authors.initials: J
authors.lastname: Chandenier
authors.forename: L
authors.initials: L
authors.lastname: Lachaud
authors.forename: L
authors.initials: L
authors.lastname: Guy
authors.forename: G
authors.initials: G
authors.lastname: Karsenty
authors.forename: C
authors.initials: C
authors.lastname: Bastide
authors.forename: J-P
authors.initials: JP
authors.lastname: Lavigne
authors.forename: A
authors.initials: A
authors.lastname: Sotto
mesh_terms: D000212:Acyclovir / Q000494:pharmacology / Q000627:therapeutic use; D015766:Albendazole / Q000494:pharmacology / Q000627:therapeutic use; D000666:Amphotericin B / Q000494:pharmacology / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D000077336:Caspofungin; D000077404:Cidofovir; D003596:Cytosine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D054714:Echinocandins / Q000494:pharmacology / Q000627:therapeutic use; D015725:Fluconazole / Q000494:pharmacology / Q000627:therapeutic use; D005437:Flucytosine / Q000494:pharmacology / Q000627:therapeutic use; D017245:Foscarnet / Q000494:pharmacology / Q000627:therapeutic use; D015774:Ganciclovir / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007559:Ivermectin / Q000494:pharmacology / Q000627:therapeutic use; D055666:Lipopeptides; D063065:Organophosphonates / Q000494:pharmacology / Q000627:therapeutic use; D011223:Praziquantel / Q000494:pharmacology / Q000627:therapeutic use; D014570:Urologic Diseases / Q000188:drug therapy* / Q000469:parasitology / Q000821:virology; D000077562:Valganciclovir
chemical_list: D000890:Anti-Infective Agents; D054714:Echinocandins; D055666:Lipopeptides; D063065:Organophosphonates; D017245:Foscarnet; D011223:Praziquantel; D007559:Ivermectin; D000666:Amphotericin B; D003596:Cytosine; D015725:Fluconazole; D005437:Flucytosine; D000077336:Caspofungin; D015766:Albendazole; D000077562:Valganciclovir; D000077404:Cidofovir; D015774:Ganciclovir; D000212:Acyclovir
keywords: Antifongiques; Antifungal; Antiparasitaires; Antiparasite treatments; Antiseptic; Antiseptiques; Antiviraux; Antivirus treatment